Abu‐Khalaf, M. M., Baumgart, M. A., Gettinger, S. N., Doddamane, I., Tuck, D. P., Hou, S., . . . Harris, L. N. (2015). Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors. Cancer (0008543X), 121(11), 1817. https://doi.org/10.1002/cncr.29254
Chicago Style (17th ed.) CitationAbu‐Khalaf, Maysa M., et al. "Phase 1b Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus in Combination with Nanoparticle Albumin-bound Paclitaxel in Patients with Advanced Solid Tumors." Cancer (0008543X) 121, no. 11 (2015): 1817. https://doi.org/10.1002/cncr.29254.
MLA (9th ed.) CitationAbu‐Khalaf, Maysa M., et al. "Phase 1b Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus in Combination with Nanoparticle Albumin-bound Paclitaxel in Patients with Advanced Solid Tumors." Cancer (0008543X), vol. 121, no. 11, 2015, p. 1817, https://doi.org/10.1002/cncr.29254.